Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study

首次发布于 2007 年 3 月 19 日

An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias

计划入组 8,000 人 · 首次发布于 2021 年 2 月 11 日

The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.

首次发布于 2015 年 7 月 20 日

Biodefence vaccines (BioSante/USAMRIID)

Traumatic brain injury (MitoSense)

CAP nanoparticles(BioSante Pharmaceuticals)

Biosense Webster Inc

United States

BIOSENSE WEBSTER, INC.

United States

CORDIS CORPORATION

United States

Omny-IRE Trial Completes Enrollment, Evaluating Biosense Webster's Pulsed Field Ablation for Atrial Fibrillation

Johnson & Johnson MedTech's Varipulse PFA System Receives FDA Approval for Atrial Fibrillation

Johnson & Johnson's Varipulse PFA System Receives FDA Approval for Atrial Fibrillation Treatment